PubMed چکیده/رکورد

Social Determinants of Guideline-Directed Oral Anticoagulation Prescription in Patients With Atrial Fibrillation Without Contraindications: Findings From the American Heart Association Get With the Guidelines-Atrial Fibrillation Registry.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

BACKGROUND: Oral anticoagulant (OAC) prescriptions recommended by atrial fibrillation guidelines to prevent stroke may be influenced by social determinants of health (SDOH). We aimed to uncover patient and institutional SDOH associated with failure to prescribe guideline-directed OAC and to develop an SDOH-based scoring system to predict failure to prescribe OAC. METHODS: We analyzed the nationwide, 249-hospital American Heart Association GWTG-AFib (Get With The Guidelines-Atrial Fibrillation) registry. We included adult patients hospitalized for atrial fibrillation with class I indication for OAC and no contraindications. Using a logistic regression model, we identified patient and institutional SDOH of failure to prescribe OAC, adjusting for the other SDOH. Next, we developed a machine learning-based prediction model in a training data set and examined the relative contribution of each SDOH. We then compared the risk of failure to prescribe OAC in an independent test data set for validation. RESULTS: Among 68 628 eligible patients, 1345 (2.0%) patients did not receive guideline-directed OAC prescription. The guideline-directed OAC prescription was influenced by both institutional SDOH (eg, hospital region, hospital size, the absence of a cardiology team) and patient SDOH (eg, sex, insurance). The absence of a cardiology team was the most important predictor (adjusted odds ratio [OR], 3.72 [95% CI, 3.20-4.32]). Patients with the higher-than-Youden-index-cutoff prediction score had higher risk of failure to prescribe OAC than those with the lower-than-cutoff prediction score (OR, 3.11 [95% CI, 2.67-3.63]). CONCLUSIONS: We identified both institutional and patient SDOH of guideline-directed OAC prescription failure. We further developed and validated a SDOH-based scoring system to predict failure to prescribe OAC.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

atrial fibrillationmachine learningoral anticoagulantssocial determinants of healthstroke
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Real-world pharmacoclinical implementation of risdiplam under a national SMA protocol: A hospital pharmacy registry-based case series.

BACKGROUND: Spinal muscular atrophy (SMA) is a rare neuromuscular disorder treated with disease-modifying therapies such as risdiplam. In Spain, its use is regulated by a national pharmacoclinical protocol that requires structured monitoring. OBJECTIVES: To evaluate real-world use, protocol adherence and registry completeness of risdiplam in routine clinical practice. METHODS: A retrospective registry-based case series was conducted in…

PubMed2026

Sex Differences in Prescribing Patterns of Anticholinergics and β3-Adrenoceptor Agonists for Overactive Bladder: A Nationwide Study in Japan, FY2017-FY2024.

OBJECTIVES: Drug treatment for overactive bladder (OAB) is changing, with an increasing share of β3-adrenoceptor agonists relative to anticholinergics, but it is not known how far this change has progressed in older people, who are most vulnerable to the risks of anticholinergics. We examined the use of these drugs in Japan by age and sex, and analyzed changes in anticholinergic burden using a large database. METHODS: We analyzed outpa…

PubMed2026

ARMED: an Australian cohort retrospective observational study to understand motivations for switching and clinical outcomes of individuals switching to dolutegravir/lamivudine.

BACKGROUND: Although clinical trials and real-world studies demonstrate the efficacy and tolerability of dolutegravir and lamivudine (DTG + 3TC), Australian real-world evidence remains limited despite differences in access to health care and prescribing context. Here, we present the motivations for switching to DTG/3TC (a fixed-dose, single-tablet regimen) and treatment outcomes. METHODS: We performed a retrospective, observational ana…

PubMed2026

Antibiotic prescribing that aligns with a host-protein test at US acute care settings is associated with fewer subsequent hospitalisations.

BACKGROUND: Differentiating bacterial from viral infections in acute care is challenging, often leading to inappropriate antibiotic use. MeMed BV (MMBV) is a host-protein test integrating TNF-related apoptosis-inducing ligand, induced protein-10 and C-reactive protein to distinguish infection aetiology. We evaluated whether alignment between MMBV results and antibiotic prescribing is associated with downstream clinical outcomes and cos…